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Abstract
Background: Biological sex plays a prominent role in the prevalence and severity of a number of important
stress-related gastrointestinal and immune-related diseases including IBS and allergy/anaphylaxis. Despite the
establishment of sex differences in these diseases, the underlying mechanisms contributing to sex differences
remain poorly understood. The objective of this study was to define the role of biological sex on mast cells (MCs),
an innate immune cell central to the pathophysiology of many GI and allergic disorders.
Methods: Twelve-week-old C57BL/6 male and female mice were exposed to immunological stress (2 h of IgE-mediated
passive systemic anaphylaxis (PSA)) or psychological stress (1 h of restraint stress (RS)) and temperature, clinical scores,
serum histamine, and intestinal permeability (for RS) were measured. Primary bone marrow-derived MCs (BMMCs) were
harvested from male and female mice and analyzed for MC degranulation, signaling pathways, mediator content,
and RNA transcriptome analysis.
Results: Sexually dimorphic responses were observed in both models of PSA and RS and in primary MCs. Compared
with male mice, female mice exhibited increased clinical scores, hypothermia, and serum histamine levels in response
to PSA and had greater intestinal permeability and serum histamine responses to RS. Primary BMMCs from female mice
exhibited increased release of β-hexosaminidase, histamine, tryptase, and TNF-α upon stimulation with IgE/DNP and
A23187. Increased mediator release in female BMMCs was not associated with increased upstream phospho-tyrosine
signaling pathways or downstream Ca2+ mobilization. Instead, increased mediator release in female MCs was
associated with markedly increased capacity for synthesis and storage of MC granule-associated immune
mediators as determined by MC mediator content and RNA transcriptome analysis.
Conclusions: These results provide a new understanding of sexual dimorphic responses in MCs and have direct
implications for stress-related diseases associated with a female predominance and MC hyperactivity including
irritable bowel syndrome, allergy, and anaphylaxis.
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Background
Biological sex is a major determinant in the prevalence
and severity of many diseases. An increasing number of
clinical and epidemiologic studies have demonstrated
that the prevalence of allergic disorders, such as urti-
caria, angioedema, allergic rhinitis, and eczema, is higher
in females than males [1–4]. In addition, women are
more likely than men to be diagnosed with allergic
asthma and develop more severe manifestations of the
disease [5, 6]. The incidence of systemic anaphylaxis is
higher in females than males, as shown in a number of
clinical and epidemiologic studies [3, 7–9]. Sex differ-
ences are well-established in gastrointestinal functional
disorders such as irritable bowel syndrome (IBS), which
is two to four times more prevalent in women than men
throughout the world [10]. Despite the known sex differ-
ences in disease prevalence and severity, the mecha-
nisms underlying these sex differences remain poorly
understood. Furthermore, there is a lack of knowledge
regarding the influence of sex in preclinical research
[11], and the inclusion of sex as a variable in cell and
tissue culture is rare [12]. While both hormonal and
non-hormonal factors have been implicated in sexual di-
morphism of disease, the reason behind female predom-
inance in these allergic and inflammatory diseases is
understudied and largely unknown.
Mast cells (MCs) are tissue-resident innate immune
cells that play a critical role in many allergic and inflam-
matory diseases. A distinguishing feature of MCs is their
numerous electron-dense secretory granules found in
their cytoplasm that are filled with potent immune me-
diators such as biogenic amines, proteases, lysosomal
enzymes, and cytokines [13]. When MCs are activated,
they undergo degranulation and release the contents of
the secretory granules into the extracellular space [14].
Released mediators have diverse and profound physio-
logical effects including increases in vascular and epithe-
lial permeability and inflammation, which lead to clinical
manifestations of disease [15]. Mast cells have central
effector functions in diseases such as allergy and IBS
[16, 17]. While there is some evidence that sex-specific
differences in these diseases are related to sex hormones,
particularly estradiol, to our knowledge, there is no in-
formation about sex-specific differences in MCs and
their contribution to the disease prevalence or severity.
Estrogen can induce MC degranulation [18–24], but
there are no studies directly addressing inherent differ-
ences that exist between MCs derived from males and
females and MC-related disease pathogenesis; therefore, a
significant knowledge gap exists regarding sex-specific dis-
ease responses with this regard. The objectives of the
present study were to investigate the influence of bio-
logical sex on MC-mediated pathophysiology in animal
models of psychological and immunological stress and to
characterize the sexually dimorphic biological responses
in primary MC cultures.
Methods
Animals
C57BL/6 mice derived from founding colony breeders
(The Jackson Laboratory, Bar Harbor, ME) were housed
under specific pathogen-free conditions in facilities accre-
dited by the Association for Assessment and Accreditation
for Laboratory Care (AAALAC) International. Mice were
group-housed with littermates in light- and temperature-
controlled and provided ad libitum access to water and a
standard commercial rodent chow diet.
Passive systemic anaphylaxis
Male and female 10–12-week-old C57BL/6 mice (The
Jackson Laboratory, Stock No: 000664) were injected in-
traperitoneally (i.p.) with 10 μg of mouse monoclonal
anti-DNP IgE. Twenty-four hours later, mice were chal-
lenged with 500 μg of 2,4-dinitrophenyl-human serum
albumin (DNP-HSA; i.p.; n = 8/sex) or PBS (i.p.; n = 4/
sex). Rectal temperatures were monitored for 120 min
post-DNP injection using a TH-5 Thermalert monitoring
thermometer with a rectal probe suitable for mice (Phy-
sitemp, Clifton, NJ). Clinical scores were also evaluated
for 120 min after DNP injection by a system adapted
from Chen et al. [25]. Briefly, the scoring system rated the
presence of the following clinical symptoms: scratching,
abdominal stretching, rubbing around nose, puffiness in
face, pilar erecti, reduced activity, increased respiration
rate, labored breathing, inability to move after prod-
ding, inability to right itself, tremors, and death. Each
symptom present added 1 point to the clinical score.
The scores were recorded by an individual who was
blinded to experimental treatments and tallied as a sum
total score for each time point. Clinical scores of mice
undergoing anaphylaxis were normalized to control
mice of respective sex.
Mice were then euthanized by CO2 inhalation, and
the mesentery of the jejunum was collected and stained
with toluidine blue (1%, pH 1) to assess tissue MC de-
granulation. Five high-power fields (×10 magnification)
of mesentery from four mice per group were randomly
chosen and MCs were counted in a blinded fashion.
For serum histamine measurements, male and female
mice (PBS, n = 4/sex; DNP-HSA, n = 4/sex, repeated in
three independent experiments) underwent the same
treatment but were sacrificed by CO2 after 30 min.
Blood was immediately collected by cardiac puncture,
and serum was harvested to evaluate histamine concen-
tration by competitive histamine ELISA (Oxford Bio-
medical Research, Rochester Hills, MI).
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Restraint stress protocol
Female and male mice, approximately 10–12 weeks of
age, were subjected to restraint stress (RS) by placing
them in individual transparent 50-ml plastic conical
tubes, modified with air holes for 15 min (n = 6/sex),
30 min (n = 6/male, n = 12/female), and 1 h (n = 5/sex).
Control mice (non-stressed) of each sex (n = 6) remained
in their original home cages for 1 h without food and
water to avoid confounding effects of water or feed in-
take during the 1-h test period. Following RS, stressed
and control mice were immediately euthanized by CO2
inhalation, and serum was collected for evaluation of
histamine concentration by competitive histamine
ELISA (Oxford Biomedical Sciences, Rochester Hills,
MI), corticosterone concentration by competitive cor-
ticosterone ELISA (Immuno-Biological Laboratories,
Inc., Minneapolis MN), and estradiol concentration by
competitive estradiol ELISA (Calbiotech Inc., El Cajon,
CA), which has been demonstrated to parallel the gold
standard method of gas chromatography/tandem mass
spectrometry [26]. Serum testosterone concentration
was measured using a solid-phase competitive chemilu-
minescent ELISA on the Siemens Immulite 2000 at the
Diagnostic Center for Population and Animal Health
(Lansing, MI). Ileal mucosa sections were collected
from non-stressed mice and stressed mice after 1-h RS
for Ussing chamber experiments.
FD4 intestinal paracellular permeability
Ileum was harvested from each animal immediately fol-
lowing euthanasia and opened lengthwise along the anti-
mesenteric border. In oxygenated (95% O2, 5% CO2)
Ringer’s solution (154 Na+ mM, 6.3 K+ mM, 137 Cl− mM,
0.3 H2PO3mM, 1.2 Ca
2+ mM, 0.7 Mg2+ mM, 24 HCO3
− at
pH 7.4) at 37 °C, the seromuscular layer was removed
from the tissue by micro-dissection. Mucosal-submucosal
sections were then mounted in a 0.3-cm2 aperture on
Ussing chambers (Physiologic Instruments, Inc., San
Diego, CA). The tissue was bathed in Ringer’s solution
containing 10 mM glucose (serosal side) that was balanced
with 10 mM mannitol on the mucosal side. Bathing solu-
tions were oxygenated (95% O2, 5% CO2) and maintained
at 37 °C. After a 30-min equilibration period on Ussing
chambers, 4 kDa fluorescein isothiocyanate dextran (FD4;
Sigma, 100 mg/ml) was added to the mucosal bathing res-
ervoir of the Ussing chambers. After a 15-min equilibra-
tion period, standards were taken from the serosal side of
each chamber and a 60-min flux period was established by
taking 0.5-ml samples from the mucosal compartment.
The quantity of FD4 was established by measuring the
fluorescence in mucosal reservoir fluid samples in a fluor-
escence plate reader at 540 nm. Data were presented as
the rate of FD4 flux in ng FD4.min.cm2.
Derivation of primary BMMCs
Bone marrow cells were isolated from the femurs of 7-
to 8-week-old male and female C57BL/6 mice and cul-
tured in complete medium containing RPMI 1640 with
L-glutamine, 10% heat-inactivated FBS, non-essential
amino acids, HEPES buffer, sodium pyruvate, 100 U/ml
penicillin, 100 μg/ml streptomycin, 5 ng/ml murine IL-3,
and 5 ng/ml murine stem cell factor (SCF). Cells were
grown at 37 °C in 5% CO2 for 4 to 8 weeks, at which
time >98% of cells in the culture were confirmed as mast
cells by toluidine blue staining (1%, pH 1) and FcεR1/c-
kit double-positive staining by flow cytometry. The n for
bone marrow-derived MC (BMMC) experiments was de-
fined by independent flasks.
pMCs
Peritoneal cells were collected from 8- to 10-week-old
C57BL/6 male and female mice by performing peritoneal
lavage with 5 ml of Hank’s Balanced Salt Solution (1×)
supplemented with EDTA (1 mM) to prevent mast cell
degranulation. Peritoneal mast cells (pMCs) were iso-
lated using a 70% Percoll gradient as previously de-
scribed [27]. Purity of separation was confirmed to be
>95% by staining with toluidine blue. Peritoneal mast
cells were counted using trypan blue exclusion, and
equal numbers of cells were lysed using radioimmuno-
precipitation (RIPA) buffer supplemented with phos-
phatase and protease inhibitors, followed by sonication
(Sonic Dismembrator Model 100, Fisher Scientific), for
later histamine measurement. Peritoneal mast cells were
collected from adult Sprague-Dawley rats by performing
peritoneal lavage with 10 ml HBSS (1×) with EDTA
(1 mM) followed by a 70% Percoll gradient as previously
described [27]. All cells were counted and equal num-
bers were lysed and sonicated for later histamine
measurement.
Mast cell activation and mediator measurement
BMMCs (2.25 × 106 cells/ml) were sensitized with 1 μg/ml
mouse monoclonal anti-DNP IgE overnight and then
stimulated with 62 ng/mL DNP-HSA for 1 h, with the
exception of the β-hexosaminidase assay which was per-
formed at multiple time points and DNP-HSA concentra-
tions (both from Sigma-Aldrich). BMMCs (2.25 × 106
cells/ml) were also stimulated with 1 μM of the Ca2+
ionophore A23187 (Sigma-Aldrich) for 1 h. The presence
of β-hexosaminidase in the supernatant and cell lysate was
evaluated using the substrate p-nitrophenyl N-acetyl-α-D-
glucosaminide. The percentage of β-hexosaminidase release
was calculated as a percentage of total β-hexosaminidase
content. For other mediators, cell supernatants were
collected and kept at −80 °C until later evaluation of medi-
ator release. Unstimulated BMMCs and pMCs were lysed
using RIPA buffer, sonicated, and kept at −80 °C until
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further analysis. Histamine levels in cell supernatants and
lysates were quantified using a competitive histamine
ELISA (Oxford Biomedical Research, Rochester Hills, MI).
Tryptase activity was measured in cell supernatants and ly-
sates, and chymase activity was measured in cell lysates
using a colorimetric activity assay with substrates (Z-Lys-
SBzl and Succ-AAPF-SBzL, respectively; Bachem, Torrance,
CA) specific for cleavage by tryptase or chymase when in
the presence of heparin, as previously described [28]. TNF-
α levels in supernatants were evaluated by quantitative
ELISA (eBioscience). Mediator levels were normalized to
unstimulated controls when applicable and corrected to
106 cells.
Quantitative real-time PCR
RNA was isolated using a RNeasy minikit (QIAGEN) from
unstimulated BMMCs and IgE-primed BMMCs stimu-
lated with 62 ng/mL DNP-HSA for 0, 1, 2, and 4 h. cDNA
(1 μg) was synthesized using the Maxima First Strand
cDNA Synthesis Kit with dsDNase (Thermo Scientific),
adhering to manufacturer’s protocol. Samples were pre-
pared according to the TaqMan Gene Expression Master
Mix (Applied Biosystems) with the following murine
primer/probe sets: Tnf (Mm00443258_m1), Il6 (Mm0
0446190_m1), Il1β (Mm00434228_m1), Il13 (Mm004
34204_m1), Ccl3 (Mm00441259_g1), Esr1 (Mm004412
59_g1), Esr2 (Mm00599821_m1), Gper1 (Mm02620
446_s1), Pgr (Mm00435628_m1), Ar (Mm00442688_m1),
Pgrmc2 (Mm01283155_m1), and Hrpt (Mm004469
68_m1). Alternatively, samples were prepared according
to LightCycler 480 SYBR 1 Green Master Mix with the
following primers: TNF-α forward, 5′-GATCGGTCCC
CAAAGGGATG-3′ and TNF-α reverse, 5′-TTGAGATC
CATGCCGTTGGC-3′; TPH1 forward, 5′-TCAAAAA
CTGGCAACGTGCT-3′ and TPH1 reverse, 5′-TACTTC
AGTCCAAACGGGCG-3′; RPL4 forward, 5′-GAAGCT
CAGTCGGGCTTCTC-3′ and RPL4 reverse, 5′-ATGTC
GACGTCGCACTTCAT-3′. Quantitative PCR was per-
formed with the 7500 Fast Real-Time PCR System (Ap-
plied Biosystems, Waltham, MA). Relative expression of
Tnf and Tph1 in unstimulated BMMCs was calculated
based on ΔCt with Rpl4 used as the endogenous control
gene. Relative expression of Esr1, Esr2, Gper1, Ar, Pgr, and
Pgrmc2 in unstimulated BMMCs was calculated based on
ΔCt with Hrpt used as the endogenous control gene.
Changes in mRNA levels of Tnf, Il6, Il1β, Il4, Il13, and
Ccl3 in IgE-DNP stimulated BMMCs were normalized to
Hrpt and relative to time point 0 h.
Phosphotyrosine expression
IgE-primed BMMCs were stimulated with 62 ng/ml of
DNP-BSA for 7 min in complete medium. Cell lysates
were then collected as described above and quantified
using a BCA reagent assay (Thermo Scientific). Samples
were separated by SDS-polyacrylamide gel electrophor-
esis (Bio-Rad) on a 4–12% XT Bis-Tris Gel (Bio-Rad)
and transferred to PVDF membrane (Bio-Rad). Blots were
probed with Phospho-Tyrosine Mouse mAb (P-Tyr-100)
and visualized with appropriate secondary antibody (both
from Cell Signaling Technology). Bands were visualized
with ChemiDoc MP imager (Bio-Rad). Densitometric
analysis was performed using Image Lab Software (Bio-
Rad) and values were normalized with β-actin.
Ca2+ mobilization experiments
BMMCs (1.25 × 106 cells/ml) were suspended in buffer
(HBSS with 20 mM HEPES) with Fluo-4 AM (Molecu-
lar Probes, Eugene, OR) at 37 °C for 1 h. DNP-HSA
(62 ng/ml) was then added to IgE-primed BMMCs, and
Ca2+ ionophore (1 μM) was added to unprimed
BMMCs. Fluo-4 AM fluorescence was monitored over
2 min using a microplate fluorometer (Fluoroskan As-
cent FL, Thermo Lab Systems) with excitation at
494 nm and emission at 516 nm. Measurements were
normalized to baseline fluorescence to evaluate calcium
mobilization in the stimulated condition. Peak fluores-
cence was calculated as the highest fluorescence value
within 2 min of stimulation and corrected with the
fluorescence value at time zero.
Transmission electron microscopy
Peritoneal cells were collected as described above. Periton-
eal cells were then pelleted, supernatant was removed, and
cells were fixed with Trump’s fixative [29]. Samples were
post-fixed for 1 h in 1% osmium tetroxide/0.15 M sodium
phosphate buffer, dehydrated through a graded series of
ethanols, and embedded in PolyBed 812 epoxy resin (Poly-
sciences, Warrington, PA). Using a diamond knife, 70-nm
sections were cut and mounted on 200-mesh copper
grids, then stained with 4% aqueous uranyl acetate for
15 min and Reynolds’ lead citrate for 8 min [30]. Samples
were observed using a LEO EM910 transmission electron
microscope operating at 80 kV (Carl Zeiss SMT, Inc.,
Peabody, MA) and digital images were acquired with a
Gatan Orius SC1000 CCD Digital Camera with Digital
Micrograph 3.11.0 (Gatan, Inc., Pleasanton, CA).
Estrous cycle characterization
Vaginal cytology was performed on adult female mice
using a fine tip pipette filled with approximately 10 μL
of physiological saline flushed into the vagina. Collected
cells were then examined by light microscopy to identify
predominant cell types and assign estrus cycle stage
(proestrus, estrus, metestrus, diestrus) as previously
described [31]. Data from metestrus and diestrus were
pooled considering the short duration of metestrus
(5–6 h) and plasma estrogen concentrations do not
differ at these stages [32]. Female mice were vaginally
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lavaged daily for at least two consecutive estrous cy-
cles and immediately prior to use in experiments. All
females in the current study were regularly cycling.
Male mice were handled in a similar manner.
High throughput RNA sequencing
RNA was extracted from unstimulated BMMCs (1.0 × 107)
derived from 2-month-old C57BL/6 male and female mice
(n = 3/sex) using an RNeasy minikit (QIAGEN). Total
RNA was sent to the North Carolina State University Gen-
omic Sciences Lab for library preparation and sequencing.
Prior to RNA library preparation and sequencing, RNA
quality and concentration were first checked on the Bioa-
nalyzer 2100 with an RNA 6000 Nano Chip (Agilent Tech-
nologies Inc., Santa Clara, CA). RIN values were >9.8 for
all samples. Poly-A mRNA was purified using the oligo-dT
beads provided in the NEBNext Poly(A) mRNA Magnetic
Isolation Module (New England BioLabs, Ipswich, MA).
Libraries were prepared using the NEBNext Ultra Dir-
ectional RNA Library Prep Kit for Illumina and indexed
with the NEBNext Mulitplex Oligos for Illumina. Briefly,
the Poly-A mRNA was chemically fragmented and
primed with random oligos for first-strand synthesis
with a heating step of 94 °C for 5 min. First-strand syn-
thesis was performed with an incubation time of 10 min
at 25 °C, 50 min at 42 °C, and 15 min at 70 °C. Second-
strand synthesis was performed with dUTPs to preserve
strand orientation information. The sample was purified,
end repaired, and dA-tailed, and NEBNext adaptors were
ligated. The ligation reaction was purified according to
the protocol for a 450-bp insert, and a 15-cycle PCR
amplification was performed, in which an index se-
quence was incorporated. The PCR product was purified
and libraries were checked for quality and concentration
on the Bioanalyzer 2100 with a High Sensitivity DNA
Chip (Agilent). Libraries were pooled in equal molar
amounts and sequenced on the Illumina HiSeq 2500
generating 100-bp SE reads. Each sample generated over
25 million SE reads.
Reads were trimmed of adapter sequences (Trimmo-
matic 0.32) to remove the TruSeq3-indexed adapter.
Reads were aligned to the GRCm38 mouse genome
using the TopHat2 program. The CuffDiff program was
performed to determine differential expression with a
significance cutoff of P < 0.05.
Statistics
Data are represented as the mean ± standard error of the
mean (SEM). Statistical analysis using GraphPad Prism 7
software was performed. Two-way ANOVA was used
when appropriate, followed by Bonferroni post hoc ana-
lysis. Two-way repeated measures ANOVA was used to
evaluate rectal temperature and clinical scoring in pas-
sive systemic anaphylaxis (PSA) model, followed by the
Bonferroni post hoc analysis. One-way ANOVA was
used for comparison of more than two groups, followed
by Tukey’s multiple comparison test. Unpaired Student’s
t test or Mann-Whitney U test as appropriate was ap-
plied to compare differences between two groups. The
sample size for each experiment was based upon previ-
ous studies and were repeated as indicated in the figure
legends. Differences between groups were considered
significant at P < 0.05.
Results
MC responses to immunological stress are sexually
dimorphic
To investigate whether female and male mice exhibited
differences in MC activation, we used a well-
characterized MC-dependent model of PSA. Adult male
and female mice were sensitized with mouse anti-DNP
IgE monoclonal antibody, via i.p. injection and then
challenged 24 h later with DNP to induce anaphylaxis.
Body temperature, clinical scores, and serum histamine
were measured as direct and indirect markers of MC ac-
tivity. Compared with male mice, female mice exhibited
a trend for more severe hypothermia when measured
over the 120-min post-PSA induction (F(1,14) = 4.118,
p = 0.0619 for sex effect; F(8.112) = 116.5, p < 0.0001 for
time effect, interaction: F(8,112) = 5.05, p < 0.0001)
while the peak drop in body temperature was signifi-
cantly greater in females (Δ body temp = −4.53 ± 0.38 °C
vs. −6.29 ± 0.45 °C in male and female mice, respectively;
p < 0.05) (Fig. 1a, b). There was also a trend for female
mice to exhibit more severe clinical symptoms of anaphyl-
axis, as indicated by increased clinical scores compared
with male mice (F(1,14) = 3.239, p = 0.0935 for sex effect,
F(13,182) = 29.11, p < 0.0001 for time effect; Fig. 1c).
Serum levels of the MC granule mediator histamine,
which is responsible for increased vascular permeability
and symptoms of anaphylaxis including hyperemia,
swelling, and hypothermia [33] were greater (by 1.8-
fold) in female mice (2032 ± 64 ng/mL) compared with
male mice (1121 ± 67 ng/mL) (F(1,12) = 96.8, p < 0.0001
for sex effect, F(1,12) = 1032, p < 0.0001 for treatment ef-
fect, interaction: F(1,12) = 93.7, p < 0.0001; Fig. 1d). To
confirm tissue MC degranulation, we evaluated tissue
MCs via toluidine blue staining in intestinal mesentery
windows. While extensive degranulation was observed
in response to PSA, there was no noticeable difference
in MC activation patterns, such as extent of degranula-
tion or percentage of MCs degranulated, between males
and females (Fig. 1e). In addition, there were compar-
able numbers of MCs present in the intestinal mesen-
tery of male and female mice, thus suggesting that
heightened anaphylactic responses were not a result of
increased MC numbers in female mice (Fig. 1f ).
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MC responses to psychological stress are sexually
dimorphic
To determine if the heightened MC responses and
pathophysiology exhibited in female mice was specific to
the IgE-dependent PSA model, we also measured MC
responses (through serum histamine levels) between
males and females in a non-IgE-dependent model of
psychological RS. Female and male mice were subjected
to short periods (15 min, 30 min, 1 h) of RS, after which
serum histamine was measured. Restraint stress induced
an elevation in serum histamine that was greater in fe-
male mice as compared to male mice, most notably at
the 15-min time point (101.6 ± 9.906 vs. 52.39 ± 3.086,
F(1,44) = 10.62, p =0.0022 for sex effect, F(3,44) = 13.1,
p < 0.0001 for time effect) (Fig. 2a). Toluidine blue
staining of intestinal mesentery confirmed that RS
led to MC degranulation in both male and female mice
(Fig. 2b). Intestinal permeability, a MC-dependent patho-
physiologic response to RS, was measured on Ussing
chambers following 1 h of RS and revealed similar findings
to serum histamine in that female mice exhibited greater
RS-induced intestinal permeability compared with males
(F(1,9) = 6.563, p = 0.0306 for sex effect, F(1,9) = 57.03,
p < 0.0001 for stress effect; Fig. 2c). Corticosterone,
the main glucocorticoid involved in stress responses
in rodents, was similarly elevated in male and female
mice after RS demonstrating a similar activation of the
hypothalamic-pituitary-adrenal axis (HPA) response in-
duced by RS in both sexes (F(1,30) = 61.5, p < 0.0001 for
stress effect; Fig. 2d). Because previous studies have shown
that stress can alter the secretion of sex steroids by inter-
fering with the hypothalamic pituitary-gonadal axis, we
determined whether serum concentrations of estradiol or
testosterone differed between male and female mice in re-
sponse to RS. As expected, serum estradiol was higher in
female mice compared with male mice under control,
non-stressed conditions (Fig. 2e). However, restraint stress
reduced serum estradiol in female mice which was in line
with previously published work [34]. However, serum
estradiol levels remained unaltered when measured at 1 h
after RS in male mice (F(1,28) = 4.629, p = 0.0402 for
interaction; Fig. 2e). Also comparable to previous studies
[35], testosterone levels were not reduced in males in re-
sponse to restraint stress (Fig. 2f). Serum testosterone
A B C
D E F
Fig. 1 PSA-induced anaphylaxis and serum histamine levels in female and male C57BL/6 mice. a Both male and female mice showed a decrease
in body temperature after injection with IgE anti-DNP antibody (10 μg/mouse, i.p.), followed 24 h later with vehicle (PBS i.p., n = 4/sex) or DNP-HSA
(500 μg/mouse, i.p., n = 8/sex). Female mice exhibited a trend (p < 0.06); Two-way ANOVA on repeated measures) (p < 0.05 with individual t-tests at
each time point) of lower body temperature than male mice after anaphylaxis challenge along with females demonstrating more severe peak
temperature drop (b). c Over the 120-min PSA challenge, females exhibited a trend of increased clinical scores of anaphylaxis, compared to males, a
difference that was statistically significant around the peak of symptoms at 60 min. d Serum levels of histamine, as measured by ELISA 30 min
after DNP (values represent results from one individual experiment with n = 4 animals/sex; results were replicated in three independent experi-
ments) showed that both male and female mice had an increase in histamine, and the increase was greater for females. e Representative pho-
tomicrographs of intestinal mesentery from male and female mice stained with toluidine blue showing increased degranulation in DNP-
treated animals; original magnification, ×100, bar = 20 μM. f The number of mast cells was similar in female and male mice. Mast cells were
counted in five randomly chosen fields per mouse. Values represent mean ± SE. †P < 0.10, *P < 0.05, #P < 0.0001
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measurements were below the limit of detection for fe-
male mice in our experiments (data not shown). Together,
results from the PSA and RS models indicate that female
mice display heightened MC activation in response to di-
verse immunological and psychological stressors which
was associated with more severe MC-associated clinical
and tissue pathophysiology.
Female BMMCs exhibit increased degranulation and
granule mediator release
Our in vivo experiments in PSA and RS models demon-
strated that females released greater amounts of histamine
and exhibited heightened MC-associated pathophysiology.
To gain further insight into this sexually dimorphic
response, we determined whether male and female MCs
exhibited different functional and (or) morphological
characteristics, utilizing primary bone marrow-derived
mast cells (BMMCs) derived from adult male and female
mice. BMMCs were sensitized overnight with DNP-
specific IgE (1 μg/mL), followed by DNP-HSA to induce
FcεR1 cross-linking and degranulation after which MC
granule mediators were measured in the supernatants.
Compared with IgE/DNP-stimulated BMMCs derived
from males, BMMCs derived from females exhibited a
greater release of β-hexosaminidase (a MC granule
marker) at multiple time points of stimulus (Fig. 3a; F(1,17)
= 59.32, p < 0.0001 for sex effect, F(4,17) = 223.1, p < 0.0001
for time effect, interaction: F(4,17) = 3.23, p = 0.0383; Fig. 3a)
and at multiple concentrations of IgE-DNP (Fig. 3b). Fe-
male BMMCs also released more histamine (by 1.7-fold),
tryptase (by 2.8-fold), and TNF-α (by 4.2-fold) in response
to IgE/DNP compared with male BMMCs (Fig. 3c–e).
Spontaneous degranulation in unstimulated conditions
was not different between male and female BMMCs with
regard to any mediators except histamine where female
BMMCs had slightly higher spontaneous release in un-
stimulated conditions (Additional file 1: Figure S1). All
stimulated mediator release was corrected with unstimu-
lated controls. Therefore, differences in spontaneous de-
granulation were not the cause of the increased mediator
release found in female BMMCs. Also, there were no no-
ticeable difference in the morphologic appearance be-
tween unstimulated male and female BMMCs upon
visualization of toluidine blue-stained slides of
BMMCs(Additional file 1: Figure S1). Despite an ex-
pected upregulation of mRNA expression for multiple
cytokines following IgE/DNP stimulation in BMMCs,
there were no differences between male and female
A B C
D E F
Fig. 2 Psychological RS-induced intestinal permeability and serum histamine levels in female and male C57BL/6 mice. a After experiencing
15 min (n = 6/sex), 30 min (n = 6/male, n = 12/female), and 1 h (n = 5/sex) of restraint stress (RS), females exhibited a statistically significant increase in
serum histamine (t-test; p<0.05), as measured by ELISA, compared to males. b Representative photomicrographs of intestinal mesentery from male and
female mice stained with toluidine blue showing increased degranulation in RS animals; original magnification, ×20, bar = 100 μM, inset; ×100, bar =
20 μM. c Distal ileum harvested after RS demonstrated increased permeability for both females and males, compared to baseline (n = 3–4/sex).
After RS, female intestinal permeability was 0.0223 ng cm2/h and male intestinal permeability was 0.0137 ng cm2/h. d Serum corticosterone in-
creased similarly in male and female mice after 30 min RS (n = 6/male, n = 12/female). e Serum estradiol decreased in female mice after
30 min of RS (n = 6/male, n = 12/female). f Serum testosterone levels were similar in males before and after RS (n = 6). Values represent mean
± SE, *P < 0.05, **P<0.01 vs. other treatments
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BMMCs, with the exception of moderately increased
expression of IL-1β in male-stimulated BMMCs (F(1,12) =
5.255, p = 0.0408 for effect, F(2,12) = 15.31, p = 0.0005 for
time effect; Additional file 2: Figure S2A-F).
Female and male BMMCs exhibit similar induction of
FcεRI-mediated phosphotyrosine signaling and intracellular
Ca2+ mobilization
To determine the mechanisms that led to increased MC
degranulation responses in female MCs, we performed
Western blotting to measure FcεR1-mediated tyrosine
phosphorylation signaling, a critical upstream signaling
event in IgE-mediated MC activation [14], in female and
male BMMCs. As expected, IgE-FcεR1 cross-linking in-
duced a robust tyrosine phosphorylation of numerous
proteins that were increased in response to IgE-DNP
treatment. However, P-tyrosine phosphorylation pat-
terns were similar between female and male BMMCs
(Fig. 4a, b). We next investigated whether differences
existed in downstream MC degranulation signaling
events. Specifically, we compared FcεRI-mediated intra-
cellular Ca2+ mobilization responses in male and female
BMMCs. Ca2+ release from intracellular endoplasmic
reticulum stores and subsequent extracellular Ca2+ entry
through store-operated Ca2+ entry (SOCE) channels are
major downstream signaling events required for MC gran-
ule fusion with the plasma membrane and granule exocyt-
osis [36]. Similar to P-tyrosine data, IgE/DNP induced a
robust increase in intracellular Ca2+; however, no differ-
ences were observed between male and female BMMCs
(Fig. 4c, d). Together, these data suggest that heightened
MC degranulation responses in female MCs were not due
to differences in upstream receptor-mediated signaling or
downstream Ca2+ mobilization mechanisms.
Female MCs contain more granule-associated mediators
Given the lack of significant differences in MC signaling
pathways described above, we next reasoned that the in-
creased mediator release in female MCs could be due to
increased MC granule mediators. Measurement of MC
granule mediators in unstimulated cell pellets indeed re-
vealed that female BMMCs contained significantly
higher concentrations of tryptase, chymase, and hista-
mine, compared with male BMMCs, (Fig. a–c). To con-
firm that increased MC granule mediator content in
female MCs was not restricted to in vitro cultured
BMMCs, we isolated tissue resident MCs from the peri-
toneal cavity of male and female mice and measured the
cellular histamine content. Consistent with the BMMC
results, female pMCs contained significantly greater his-
tamine content compared with male pMCs (Fig. 5d).
The increased histamine content in female MCs was also
confirmed in rat pMCs (Fig. 5e), demonstrating that in-
creased MC mediator content in females was not spe-
cific to mice. To further characterize the differences in
female and male MCs, we evaluated mouse pMCs at the
A B C D
E
Fig. 3 Female BMMCs release more preformed mediators in response to IgE-mediated degranulation. BMMCs were sensitized with anti-DNP IgE
(1 μg/mL) overnight and later stimulated with DNP-HSA. a Male and female BMMCs were stimulated with 0, 15, 31, and 62 ng/mL of DNP-HSA
for 1 h and female BMMCs exhibited elevated β-hexosaminidase release at all DNP concentrations (P < 0.05; n = 6). b Compared with male
BMMCs, female BMMCs had an increased release of β-hexosaminidase after 30, 45, 60, and 90 min of DNP-HSA stimulus (62 ng/mL). c Female
BMMCs released 141.9 ng/106 cells of histamine into supernatant and male BMMCs released 83.7 ng/106 cells of histamine after 1 h DNP stimulus
(62 ng/mL) (P < 0.001; n = 5). d Tryptic activity from female BMMCs increased to 5.3 after degranulation, and tryptic activity from male BMMCs was
1.9 after degranulation with 1 h DNP stimulus (62 ng/mL) (P < 0.05; n = 6). e Female BMMCs released 107.4 pg of TNF-α into supernatant and male
BMMCs released 25.5 pg after 1 h DNP stimulus (62 ng/mL) (P < 0.001; n = 5). All mediator release was normalized to unstimulated cells of respective
sex. Values represent mean ± SE. #P = 0.10 *P < 0.05, **P<0.01 ***P < 0.001 vs. males
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ultrastructural level using TEM [26]. In agreement with
MC mediator data, MC granules from female pMCs
visually had increased density compared with male
pMCs (Fig. 5f ). Together, these data demonstrate that
MCs from females contain more granule-associated im-
mune mediators compared with male MCs.
As an additional functional experiment to confirm that
the increased granule mediator content in female mice
was contributing to heightened mediator release during
degranulation, we measured MC degranulation and Ca2+
mobilization in BMMCs in response to the Ca2+ iono-
phore A23187, which acts downstream of receptor activa-
tion to trigger Ca2+ influx and MC degranulation. Similar
to IgE/DNP-stimulation responses, female BMMCs re-
leased greater amounts of β-hexosaminidase, histamine,
tryptase, and TNF-α in response to A23187 than male
BMMCs. Also in line with IgE/DNP stimulation, there
were no differences in Ca2+ mobilization responses be-
tween male and female BMMCs (Fig. 6a–f ).
Sexual dimorphic MC responses are not influenced by
estrous cycle
The estrous cycle, characterized by fluctuations of ovarian
steroid hormones, has been shown to influence MC dens-
ity and phenotype in multiple rodent tissues [37, 38].
Therefore, we sought to evaluate whether the estrous
cycle was influencing the sexually dimorphic MC
pathophysiology and phenotype demonstrated in the
present study. Serum histamine levels following RS did
not differ between female mice in different stages of the
estrous cycle (Fig. 7a). Similarly, no differences were found
in histamine content of pMCs in female mice with regard
to the estrous cycle (Fig. 7b). Interestingly, a mildly in-
creased number of pMCs was found in female mice in
proestrus and estrus in comparison to Met/Diestrus, simi-
lar to findings previously discovered in rat mammary
gland tissue (F(3,14) = 4.303, p = 0.0239; Fig. 7c) [39].
Sex steroid hormones, in particular estradiol, have been
previously demonstrated to induce mild degranulation in
BMMCs [19, 21]. Therefore, we evaluated whether sex
steroid receptors were differentially expressed on male
and female BMMCs, providing another potential mechan-
ism for increased MC degranulation responses in female
BMMCS. These studies revealed that female BMMCs had
higher mRNA expression of Esr1 and Ar correlating to es-
trogen receptor α and androgen receptor, respectively
(Additional file 3: Figure S3A-F).
Transcriptomic analysis in BMMCs reveals sexual
dimorphism
To gain a more fundamental understanding of why MCs
from females contained increased MC granule mediators,
we profiled the gene expression patterns in MCs from
males and females using RNA sequencing technology
A B
C D
Fig. 4 FcεRI-mediated p-tyrosine expression and Ca2+ mobilization in female and male murine BMMCs. After sensitization with anti-DNP IgE,
BMMCs were stimulated with DNP-HSA (62 ng/ml) for 7 min. Results from female and male BMMCs showed no differences in a tyrosine
phosphorylation of proteins after FcεRI engagement, b quantification of tyrosine-phosphorylated proteins (n = 4), or Ca2+ influx as indicated by
Ca2+ tracings (c) and quantified as the d change in peak fluorescence (n = 3). Values represent mean ± SE
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(Illumina HiSeq 2500) with RNA extracted from unstimu-
lated BMMCs (1.0 × 107 cells). Remarkably, a total of 8233
genes were expressed differentially between male and fe-
male BMMCs (Fig. 8a). This finding demonstrates that,
while male and female cells are generally assumed to have
very similar autosomal genomes, the expression of the
genome can vary immensely between the sexes. The Xist
gene, which is exclusively expressed from the inactive X
chromosome in females, had the greatest differential
expression in females (9.9-fold) [40]. Similarly, two Y
chromosome genes, Eif2s3y and Kdm5d, had the greatest
differential expression in males (7.6-fold and 8.6-fold, re-
spectively). These results validate RNA sequencing to de-
termine sex-specific differences in BMMCs.
We next evaluated gene ontology for biological pro-
cesses between male and female BMMCs using Protein
ANalysis THrough Evolutionary Relationships software
(PANTHER), focusing on the genes with >2-fold differ-
ence in expression (Fig. 8b). Interestingly, MCs from fe-
males had more than twice as many upregulated genes
(552 vs. 250 genes) involved in biological processes com-
pared with MCs from males. Of particular interest to
our current findings, the metabolic processes category
had 300 genes upregulated in females vs. 89 in males,
and within this category, biosynthetic processes had 35
genes upregulated in females and only 1 in males. Fe-
male BMMCs also exhibited higher expression of genes
in cellular processes, especially genes involved in the cell
cycle, as well as higher expression of genes in cellular
component organization and biogenesis than male
BMMCs.
Considering our findings that female MCs contain
more intracellular granule mediators than male MCs, we
next investigated whether genes for immune mediators
known to be stored in preformed granules of MCs were
upregulated in females (Table 1). We found that Tnf
gene expression was 3.48-fold higher in female BMMCs.
Mast cell protease 1, which is a β-chymase often
associated with mucosal MCs and abundantly found in
BMMCs, was found to be 2.70-fold higher in female
BMMCs [41]. Mcpt2, mcpt4, and mcpt8 were also found
to have higher gene expression in female BMMCs than
male BMMCs, as well as the gene for the alpha subunit
of the lysosomal hydrolase β-hexosaminidase, Hexa.
Surprisingly, tryptase beta 2 was found to be downreg-
ulated in female BMMCs, which does not correlate with
A B C
D E F
Fig. 5 Female mast cells contain more granule-associated mediators than male mast cells. a The total tryptic activity of unstimulated female
BMMCs was higher than that of male BMMCs (21.2 vs. 14.5; P < 0.01; n = 5). b The total chymase activity of unstimulated female BMMCs was
higher than that of male BMMCs (9.0 vs. 6.4; P < 0.01; n = 3). c The total histamine content of unstimulated female BMMCs was higher than that
of male BMMCs (827.7 vs. 487.8; P < 0.05; n = 5). d The total histamine content of female mouse pMCs was higher than that of male pMCs (35,489
vs. 22,673; P < 0.01; n = 7/male, n = 11/female). e The total histamine content of pMCs from female rats was higher than that of male rat pMCs
(71,806 vs. 43,167; P < 0.001 n = 3). f Representative images of peritoneal mast cells recovered and pooled from five, 8-week-old male and female
C57BL/6 mice and analyzed by TEM. Scale bar = 2 μm. All values were normalized to cell number. Values represent mean ± SE. *P < 0.05, **P < 0.01,
***P < 0.001 vs. males
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our finding that female mast cells have increased tryptic
activity. However, while protein concentration generally
correlates with the abundance of the corresponding
mRNAs, regulation of post-transcription, translation, and
protein degradation determines functional protein abun-
dance [42]. Gene expression for the most abundant MC-
associated cathepsins (G, C, L, and S [43]) were all upregu-
lated in females. Gene expression of key enzymes involved
in the first steps of synthesizing histidine and tryptophan,
phosphoribosyl pyrophosphate synthetase 1 and 2, were
found to be upregulated in female BMMCs as well as a
gene for the enzyme tryptophan hydroxylase, which
Fig. 7 Influence of the estrous cycle on serum histamine response and tissue MC histamine content and number. a After experiencing 30 min of
RS, serum histamine levels were similar between female mice in all stages of the estrous cycle. b The total histamine content of mouse female
pMCs was similar at each stage of the estrous cycle. c During proestrus and estrus, female mice had higher numbers of pMCs than male mice.
Values represent mean ± SE. *P < 0.05 vs. males
A B C
D E F
Fig. 6 A23187-induced degranulation and Ca2+ mobilization in female and male murine BMMCs. BMMCs were stimulated for 1 h with the Ca2+
ionophore, A23187 (1 μM). a BMMCs from females showed a 50.6% increase in β-hexosaminidase release and male BMMCs showed a 39.9% in-
crease, a difference that was significant (P < 0.001; n = 6). b Female BMMCs released 406.1 ng/106 cells of histamine into supernatant and male
BMMCs released 159.3 ng/106 cells of histamine (P < 0.001; n = 5). c Tryptic activity (ΔOD405/min/106 cells) from female BMMCs increased to 7.6
after degranulation, and tryptic activity from male BMMCs was 3.2 after degranulation (P < 0.001; n = 4). d Female BMMCs released 165.7 pg of
TNF-α into supernatant and male BMMCs released 103.4 pg (P < 0.01; n = 4). All mediator release was normalized to unstimulated cells of
respective sex. e Female and male BMMCs exhibited similar Ca2+ influx as measured by e Ca2+ tracings and quantified as the f change in peak
fluorescence after stimulation with A23187 (1 μM). Values represent mean ± SE. **P < 0.01, ***P < 0.001 vs. males
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converts tryptophan to serotonin [44–46]. Together, these
data demonstrate a higher expression in females than
males of numerous genes involved in forming immune me-
diators that are stored in preformed secretory granules in
BMMCs and further support our findings in vitro.
We also evaluated whether genes involved in MC
granule biogenesis and maturation were increased in fe-
male MCs because of the increased mediator content
found in the granules of female MCs (Table 2). Srm,
Odc1, and Sms, which are genes involved in polyamine
synthesis and therefore granule maturation, were upreg-
ulated in female BMMCs [47]. Another gene involved in
granule maturation that was upregulated in female mast
cells was Bhlha15, which is also referred to as Mist1.
Rab5 is a small GTPase known to play an important role
in granule biogenesis in mast cells, and the gene Rab5c
was upregulated in females [48]. Genes Ap1m1 and M6pr,
which code for proteins that sort mediators into vesicles/
granules, were upregulated in female BMMCs [49, 50].
Many genes in the Atp6v family, which correspond to pro-
teins that help acidify granule lumens, were also upregu-
lated in female BMMCs, and two were upregulated in
male BMMCs [51]. Two notable genes involved in granule
formation and vacuole acidification, Lyst and Slc18a2,
were downregulated in females [52, 53].
Our data demonstrating higher protein levels of hista-
mine, tryptase, and chymase in female BMMCs, along
with increased mRNA expression in female BMMCs for
Tnf and Tph1 genes with qRT-PCR (Additional file 4:
Figure S4 A-B), agree with the differential gene expression
discovered through RNA sequencing. Overall, these find-
ings indicate that MCs derived from females have in-
creased expression of many genes involved in granule
biogenesis and maturation compared to MCs from males.
The differences in gene expression may explain the forma-
tion of granules with increased mediator content found in
female MCs.
Discussion
The incidence, onset, and severity of many allergic, in-
flammatory diseases, and functional bowel diseases in
which the MC is a central perpetrator of pathology are
known to exhibit a sex difference. The mechanisms
underlying sex-related differences in these diseases re-
main poorly understood. Here, we demonstrate that
MCs from males and female mice exhibit distinct and
vast biological differences related to their transcriptome
and synthesis and storage of MC granule mediators.
These differences were associated with increased re-
lease of MC mediators and pathophysiological re-
sponses to allergic and psychological stress-induced
disease in females.
In the present study, female mice exhibited markedly
higher IgE-mediated serum histamine responses and more
severe anaphylaxis (clinical scores and hypothermia) com-
pared with male mice. Furthermore, we demonstrated that
heightened MC responses and associated pathophysiology
in female mice were not restricted to IgE-dependent
models of PSA, as female mice exposed to a psychological
RS exhibited greater serum histamine responses and
Fig. 8 Sexually dimorphic gene expression in BMMCs from C57BL/6 mice. a A total of 8233 genes were found to be differentially expressed
between 6-week-old male and female BMMCs using RNA-sequencing technology (Illumina HiSeq 2500) (n = 3). b There were many genes that
code for proteins involved in cellular processes and metabolic processes that were upregulated in females compared to males
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intestinal permeability without differences in cortico-
sterone secretions between the sexes. Findings from the
RS model have particular relevance to highly prevalent
functional GI disorders such as IBS, for which psycho-
logical stress is a major risk factor; females are two to four
times more likely than males to develop IBS [10, 54, 55].
Sex is increasingly understood to be an important vari-
able influencing disease, and more research models are
investigating these sex differences [11, 56]. Previous
studies addressing the influence of sex on MC responses
have focused primarily on the effects of sex hormones,
particularly the direct effects of estrogen on in vitro MC
degranulation [18–24]. These studies showed that estro-
gen signaling could enhance degranulation in MCs, indi-
cating a role for sex hormones in promoting MC
degranulation. Hox et al. [57] demonstrated that female
C57BL/6 mice developed more severe hypothermia in
response to PSA [57], which supports our findings in the
present study. The authors also showed that ovariectomy
reduced the magnitude of hypothermia; however, ovari-
ectomized female mice in their study were not directly
compared with a male cohort in that experiment and
thus could not conclude that estrogen alone was respon-
sible for the sex differences observed. In contrast to our
findings presented here, Hox et al. [57] reported that,
despite the increased hypothermia observed in female
mice in their study, there were no differences in serum
histamine responses between males and females in PSA.
One key difference that likely explains the differences
between our results and that from Hox et al. [57] is that
they measured serum histamine 90 s after inducing ana-
phylaxis, whereas we measured serum histamine 30 min
after inducing anaphylaxis, when serum histamine levels
have been shown to reach their peak values [58].
Table 1 Expression of genes in female BMMCs relative to male BMMCs, involved in forming immune mediators stored in mast cell
granules
Gene name Gene
symbol
Comments Statistics
Log2 fold change q value
Tumor necrosis factor Tnf Proinflammatory cytokine stored in preformed mast cell granules
(Gordon & Galli 1990 [81])
3.48 0.00016
Mast cell protease 1 Mcpt1 B-chymase involved in maintaining granule structure (Wastling 1998 [82])
and inflammation at mucosal sites [41]
2.70 0.015
Mast cell protease 2 Mcpt2 Enzymatically inactive chymase without known function (Caughley 2011 [83]) 0.64 0.00016
Mast cell protease 4 Mcpt4 Functional equivalent to human mast cell chymase (Caughley 2015 [43]) 0.39 0.037
Mast cell protease 8 Mcpt8 Serine protease more closely related to granzymes and cathepsin G than
chymases (Lutzelschwab 1998 [84])
1.71 0.00016
Tryptase beta 2 Tpsb2 Serine protease important for pathology in a variety of inflammatory
conditions (Payne 2004 [85])
−1.35 0.00016
Cathepsin B Ctsb Cysteine protease that processes protryptase to mature tryptase (Le 2011a [86]) 0.31 0.015
Cathepsin C Ctsc Cysteine protease that is an upstream activator of tryptases, chymases, and
cathepsin G (Caughley 2015 [43])
0.99 0.00016
Cathepsin G Ctsg Serine protease with tryptic and chymotryptic activity (Caughley 2007 [87]) 1.16 0.00016
Cathepsin H Ctsh Cysteine protease that may be involved in tumor progression (Schweiger 2004 [88]) 1.28 0.0099
Cathepsin K Ctsk Cysteine protease that degrades type 1 collagen (Bone 2004 [89]) 1.71 0.00016
Cathepsin L Ctsl Cysteine protease that processes protryptase to mature tryptase (Le 2011a [86]) 1.09 0.00016
Cathepsin S Ctss Cysteine protease linked to inflammatory processes such as atherosclerosis,
asthma, and atopic dermatitis [20]
1.28 0.00016
Cathepsin Z Ctsz Cysteine protease involved in enhanced metastasis in various cancers (Wang 2011 [90]) 1.02 0.00016
Cathepsin E Ctse Aspartic protease that processes procarboxypeptidase (Henningsson 2005 [91]) −2.05 0.00016
Cathepsin F Ctsf Cysteine protease most notably found in neural tissue (Tang 2006 [92]) −2.46 0.00016
Cathepsin O Ctso Cysteine protease with endoprotease activity (Zhang 2015 [93]) −1.09 0.00016
B-hexosaminidase subunit alpha Hexa Alpha subunit of the lysosomal hydrolase B-hexosaminidase, an important
enzyme in defense against pathogens (Fukuishi 2014 [94])
0.32 0.0038
Phosphoribosyl pyrophosphate
synthetase 1
Prps1 Key enzyme involved in histidine and tryptophan synthesis [68, 44] 2.45 0.00016
Phosphoribosyl pyrophosphate
synthetase 2
Prps2 Key enzyme involved in histidine and tryptophan synthesis [68, 44] 0.54 0.00074
Tryptophan hydroxylase 1 Tph1 Key enzyme in the synthesis of serotonin from tryptophan (Nowak 2012 [49]) 0.55 0.0011
Q values <0.05 are considered significant
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In the present study, we demonstrated that primary
MCs derived from female mice and rats possessed an in-
creased capacity for MC mediator synthesis and granule
storage compared with males. This resulted in an in-
creased amount of MC granule mediator release as dem-
onstrated by higher levels of β-hexosaminidase, TNF-α,
tryptase, and histamine upon FcεR1 crosslinking and
A12387-induced MC degranulation. As reported above,
previously published work suggests a role for the direct
stimulatory effects of estrogen on MC degranulation in
culture. The findings from the current study are differ-
ent from previous studies as we describe increased abil-
ity of female stem-cell derived MCs to synthesize and
store more mediators in the absence of exogenous estro-
gen. Thus, the sexually dimorphic effects on MC pheno-
type can be assumed to be predetermined. Our findings
are supported by a previous study showing that pMCs
from female rats had higher histamine levels than pMCs
from male rats (275.0 and 46.61 fluorescence intensity
units, respectively), but this was not statistically
significant, possibly due to a large standard deviation in
the data [59]. Our experiments in the present study also
confirmed that the elevated MC mediator release from
female MCs was not associated with increased upstream
p-tyrosine signaling pathways or downstream elevated
intracellular Ca2+ mobilization. These findings also cor-
roborated with our findings that female MCs exhibited
higher release of MC mediators in response to A21387,
a Ca2+ ionophore that degranulates MCs predominantly
via downstream influx of extracellular Ca2+. Overall,
these new findings are significant because they represent
a new mechanism, other than direct stimulatory effects
of sex hormones, which may contribute to the increased
prevalence and severity of MC-mediated diseases in
females.
There is epidemiological evidence that the estrous
cycle, characterized by fluctuations in sex hormones,
namely estrogen and progesterone, influences the sever-
ity of MC-associated disease in females [60–62]. Studies
in rodents have shown that in multiple tissues, MC
Table 2 Expression of genes in female BMMCs relative to male BMMCs, involving granule biogenesis and maturation
Gene name Gene
symbol
Comments Statistics
Log2 fold
change
q value
Spermidine synthetase Srm Synthesizes polyamines important in granule biogenesis and homeostasis,
including storage of histamine and proteases (Garcia-Faroldi, 2010 [47])
3.68 0.00016
Ornithine decarboxylase 1 Odc1 Synthesizes polyamines important in granule biogenesis and homeostasis,
including storage of histamine and proteases (Garcia-Faroldi, 2010 [47])
2.52 0.00016
Spermine synthetase Sms Synthesizes polyamines important in granule biogenesis and homesostasis,
including storage of histamine and proteases (Garcia-Faroldi, 2010 [47])
0.54 0.0045
Basic helix-loop-helix family,
member A15
Bhlha15 Important transcription factor in forming mature secretory granules in a
variety of specialized secretory cells (Tian 2010 [72])
3.42 0.00016
Rab5c, member of Ras oncogene family Rab5c Key regulator of mast cell granule fusion during biogenesis (Azouz 2014 [48]) 0.62 0.00032
Mannose-6-phosphate receptor M6pr Transports glycosylated proteins, such as lysosomal hydrolases and TNF,
into vesicles (Coutinho 2012 [50], Olszewski 2006 [73])
0.43 0.00016
Adaptor protein 1A complex Ap1m1 Protein necessary for the sorting of proteins into vesicles and secretory
granule maturation (Bonnemaison 2014 [49])
0.36 0.0033
ATPase, H+ transporting, lysosomal
16 kDa, V0 subunit c
Atp6v0c Component of a vacuolar type H+ ATPase that acidifies granule lumen for
condensation of granule contents (Borges 2011)
0.69 0.00016
ATPase, H+ transporting, lysosomal
50/57 kDa, V1 subunit H
Atp6v1h Component of a vacuolar type H+ ATPase that acidifies granule lumen for
condensation of granule contents (Borges 2011)
0.52 0.00016
ATPase, H+ transporting, lysosomal
V0 subunit a2
Atp6v0a2 Component of a vacuolar type H+ ATPase that acidifies granule lumen for
condensation of granule contents (Borges 2011)
0.46 0.00016
ATPase, H+ transporting, lysosomal
50/57 kDa, V1 subunit H
Atp6v1a Component of a vacuolar type H+ ATPase that acidifies granule lumen for
condensation of granule contents (Borges 2011)
0.42 0.020
ATPase, H+ transporting, lysosomal
9 kDa, V0 subunit e1
Atp6v0e Component of a vacuolar type H+ ATPase that acidifies granule lumen for
condensation of granule contents (Borges 2011)
0.32 0.0044
ATPase, H+ transporting, lysosomal
34 kDa, V1 subunit D
Atp6v1d Component of a vacuolar type H+ ATPase that acidifies granule lumen for
condensation of granule contents (Borges 2011)
−0.24 0.038
ATPase, H+ transporting, lysosomal
13 kDa, V1 subunit G2
Atp6v1g2 Component of a vacuolar type H+ ATPase that acidifies granule lumen for
condensation of granule contents (Borges 2011)
−1.84 0.00016
Lysosomal trafficking regulator Lyst Important regulator of granule formation (Durchfort 2012 [95], Hammel 2010 [52]) −1.29 0.00016
Solute carrier family 18, member 2 Slc18a2 Transports histamine and serotonin into granules (Merickel 1995 [96]) −0.92 0.00016
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presence and staining properties can be influenced by
stage of estrous cycle [37–39]. In the present study,
serum histamine levels after RS and histamine content
in pMCS were independent of estrous cycle stage, while
slightly higher pMC numbers were found during proes-
trus and estrus in female mice. This suggests that the
sexually dimorphic responses seen in MC disease patho-
physiology were not dependent solely on the effects of
sex hormones, but instead, other factors must be in-
volved in programming the sexually dimorphic pheno-
type of the MC.
RNA sequencing analysis in BMMCs derived from
sexually mature female and male mice revealed that, at
baseline conditions (unstimulated), there were over 8000
differentially expressed genes. Specifically, our analysis
revealed upregulation of multiple genes associated with
the formation of immune mediators stored in preformed
granules, thus supporting our cell culture and in vivo
data. Sexually dimorphic gene expression has been dem-
onstrated in a wide variety of organisms from worms to
primates [63]. A study by Yang et al. [64] found that
mouse liver, adipose, and muscle tissue all had tissue-
specific sexually dimorphic gene expression, in which
thousands of genes were differentially expressed between
the sexes. Many studies have also demonstrated a large
number of differentially expressed genes between the
sexes in human tissues, such as peripheral blood, skeletal
muscle, T cells, and jejunum [40, 65–67]. Therefore, al-
though sex differences at the DNA level are restricted to
the sex chromosomes, transcription of DNA differs
widely between the sexes across many species and in
many tissues. Of particular relevance to our in vivo and
in vitro MC culture experiments was that the phosphori-
bosyl pyrophosphate synthetase enzymes were upregu-
lated in female BMMCs. These enzymes are crucial to
synthesize histidine and tryptophan, which are then con-
verted to the preformed immune mediators histamine
and serotonin, found in mast cell granules [44, 68].
Interestingly, the genes prps1 and prps2 map to the X
chromosome, and the rate of transcription of prps1 in
particular determines the rate of production for phos-
phoribosyl phosphate, which in turn can be converted to
histidine and tryptophan [69]. The increased biosyn-
thesis of these amino acids may lead to an increased
stock of product to be converted by histidine decarb-
oxylase and tryptophan hydrolase to histamine and sero-
tonin that are stored in mast cell granules. Therefore,
although the gene for histidine decarboxylase, an im-
portant enzyme in histamine synthesis and granule mat-
uration, was not upregulated in female BMMCs in the
present study; the increased histamine storage in female
BMMCs may be a result of the larger stores of histidine
to be converted into histamine [70]. In addition, the
gene for tryptophan hydrolase, the enzyme that converts
tryptophan to serotonin, was upregulated in female
BMMCs, suggesting that female MCs may contain
higher levels of serotonin through increased stores of
tryptophan and more enzyme for conversion. The gene
for TNF-α was one of the most differentially expressed
genes between male and female BMMCs, which corre-
lated with our finding that female BMMCs release more
TNF-α upon stimulation than male BMMCs. We also
discovered increased gene expression of multiple chy-
mases in female BMMCs as well as increased chymase
protein activity. Surprisingly, a gene for tryptase was
downregulated in female BMMCs even though female
BMMCs had greater tryptase activity. However, post-
transcriptional regulatory pathways influence functional
protein abundance, which may explain our findings [42].
Numerous cathepsins were upregulated in female
BMMCs and many of these cysteine proteases are up-
stream activators of the enzymatically inactive pro-
tryptase to the mature form of tryptase, which may be
another factor for the higher level of active tryptase
found in female BMMCs [43]. Taken together, the se-
quencing results here demonstrate sexual dimorphism in
MC gene expression which correlate with our in vivo
and in vitro experiments.
Another interesting finding is the higher gene expres-
sion in female BMMCs than male BMMCs of the three
main enzymes involved in polyamine synthesis. Poly-
amines are small polycations found in all mammalian
cells that are important for a variety of cellular functions
including chromatin condensation, DNA replication,
transcription, translation, and protein activation [71].
Polyamines have a unique role in MCs because they are
stored in MC granules and also necessary for dense core
formation and histamine storage in MC granules [47]
which also confirming our findings of increased hista-
mine content in female MCs.
A gene that was also highly upregulated in female
mast cells is Bhlha15, which is also referred to as Mist1.
MIST1 is a transcription factor associated with cells that
have high secretory activity, such as immunoglobulin se-
creting cells, alveolar breast lobular cells, and gastric
zymogenic cells [72]. Mist1-null mice were shown to
have small, underdeveloped secretory vesicles in zymo-
genic chief cells, demonstrating the importance of this
transcription factor in vesicle formation and maturation,
which may explain our findings in female MCs [72]. The
mannose-6-phosphate pathway has been implicated in
sorting glycosylated proteins with an M6P group (lyso-
somal hydrolases and TNF-α) into lysosomes [50, 73].
The mannose-6-phosphate receptor gene was upregu-
lated in female MCs, which potentially allows in-
creased transport of TNF-α and acid hydrolases (e.g.,
β-hexosaminidase) into female MC granules. The
adaptor protein 1A complex (AP-1A), encoded by
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Ap1m1, is known to facilitate protein entry into vesi-
cles, and blocking AP-1A led to the formation of im-
mature secretory granules in AtT-20 corticotrope
tumor cells [49]. The higher expression of this gene in
female BMMCs compared to male BMMCs could po-
tentially influence the increased storage of female MC
granules. Five genes involving the vacuolar type H+
ATPase (V-ATPase) were upregulated in females, and
two were downregulated. V-ATPase is involved in acid-
ifying granule lumens to condense the contents and,
therefore, may be involved in increasing the amount of
mediators stored in granules [51].
Upon pathways analysis, a particularly interesting find-
ing is that female BMMCs have higher expression of
genes involved in metabolic pathways, including many of
the biosynthetic and energy-generating pathways. Female
BMMCs also had higher gene expression in cellular
component organization and biogenesis than male
BMMCs, including ribosome biosynthesis. These find-
ings correlate with the ability of female MCs to be more
actively producing cells that store and release more im-
mune mediators than male MCs.
Regardless, there may be other factors involved in the
transcriptomic and phenotypic differences found be-
tween male and female MCs in our study. One possibil-
ity is that sex could be influencing the epigenetic code of
the cells causing sex-specific chromatin remodeling and,
therefore, regulating which genes are expressed. A previ-
ous study demonstrated that sex is an important factor
in DNA methylation status, which is important in alter-
ing chromatin structure and gene expression [74]. Estro-
gen can influence methylation patterns, and it is possible
that, in the stem cells we collected, sex hormones caused
epigenetic changes that had long-lasting effects on gen-
ome expression and stem cell development into MCs
[75, 76]. The complement of sex chromosomes in a cell
can also influence genome-wide DNA methylation in a
hormone-independent fashion, demonstrating that sex
hormones are not the only variable involved in the sex-
ual dimorphism seen in MCs [77].
The X chromosome contains approximately 1100
genes, many of which are involved in immunity [78]. Fe-
males inherit two X chromosomes, one of which is ran-
domly silenced during X chromosome inactivation, but
previous studies showed up to 7% of genes escape silen-
cing from the inactive X chromosome in mouse tissues
[79] and 15% in human cells [80]. The effect of gene es-
cape from X chromosome inactivation is not known, but
extra expression of genes potentially involved in immun-
ity may have large consequences on the development
and activity of the cell.
In summary, the data presented here demonstrate the
sexual dimorphism that exists in the transcriptome and
biology of MCs and in the pathophysiologic responses to
immunological and psychological stressors. Our data
here demonstrate that female rodent MCs possessed an
increased capacity to synthesize and store granule medi-
ators, contributing to the elevated release of MC granule
mediators and associated downstream pathophysio-
logical and clinical responses. These new findings are
likely to have important implications for diseases such as
allergy/anaphylaxis and IBS, where the prevalence and
disease severity is greater in females.
Conclusions
The present study demonstrates that MCs exhibit
marked, sexually dimorphic responses in that female
MCs exhibit increased synthesis, storage, and release of
MC granule-associated mediators that is independent of
the estrous cycle. Differences observed in female MCs
translated to a heightened tissue MC degranulation re-
sponse and more severe systemic and intestinal disease
activity in murine models of immunological and psycho-
logical stress. Together, these data provide a new under-
standing of the influence of biological sex on MC biology
and disease. Further elucidation of the mechanisms
driving sexual dimorphism in MCs could result in new
sex-specific therapeutic targets for stress-related MC dis-
orders exhibiting a female predominance including IBS
and allergy.
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Additional file 1: Figure S1. Basal release of histamine and
morphological appearance of female and male BMMCs. (a) Female
BMMCs released 36.0 ng/106 cells of histamine into supernatant and
male BMMCs released 19.4 ng/106 cells of histamine in unstimulated
conditions (P < 0.05; n = 5). (b) Representative photomicrographs of male
and female BMMCs showing no noticeable differences in cell morphology
between the sexes in unstimulated conditions. Values represent mean ± SE.
*P < 0.05 vs. males. (PDF 135 kb)
Additional file 2: Figure S2. Cytokine mRNA expression of IgE-DNP
stimulated female and male BMMCS. (a–f) Real-time quantitative PCR of
Tnf, Il6, Il1β, Il4, Il13, and Ccl3 mRNA transcripts from IgE-DNP stimulated
male and female BMMCs at 0, 1, 2, and 4 h normalized to Hrpt and
relative to 0 h (n = 3). Values represent mean ± SE. *P < 0.05. (PDF 83 kb)
Additional file 3: Figure S3. Sex steroid receptor gene expression in
female and male BMMCs. (a–f) Real-time quantitative PCR of Esr1, Esr2,
Gper1, Ar, Pgr, Pgrmc2 mRNA transcripts from unstimulated male and
female BMMCs normalized to Hrpt (n = 3). Values represent mean ± SE.
*P < 0.05, **P < 0.01 vs. males. (PDF 69 kb)
Additional file 4: Figure S4. Tnf and Tph1 gene expression in female
and male BMMCs. (a) Real-time quantitative PCR of Tnf mRNA transcripts
from 6 week-old male and female BMMCs normalized to Rpl4 (n = 3). (b)
Real-time quantitative PCR of Tph1 mRNA transcripts from 6 week-old
male and female BMMCs normalized to Rpl4 (n = 3). Values represent
mean ± SE. †P < 0.10, *P < 0.05 vs. males. (PDF 102 kb)
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